Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
- DOI
- 10.3389/fphar.2021.786706
- Published
- 2022-01-25
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2021.786706,
title = {Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers},
author = {Sok Cin Tye and Sieta T. de Vries and Christoph Wanner and Petra Denig and Hiddo J. L. Heerspink},
year = {2022},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2021.786706},
url = {https://doi.org/10.3389/fphar.2021.786706}
}RIS
TY - JOUR TI - Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers AU - Sok Cin Tye AU - Sieta T. de Vries AU - Christoph Wanner AU - Petra Denig AU - Hiddo J. L. Heerspink PY - 2022 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2021.786706 UR - https://doi.org/10.3389/fphar.2021.786706 ER -
APA
Tye, S. C., Vries, S. T. D., Wanner, C., Denig, P., & Heerspink, H. J. L. (2022). Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.786706
Source records
- crossref · retrieved 2026-09-25T00:34:34.089Z